Most pivotal clinical trials, including the STEP, SURMOUNT, REDEFINE, and TRIUMPH programs, have evaluated treatment durations ranging from 36 to 72 weeks, with no randomized evidence extending beyond two years
At Concorde, we focus not only on eligibility and appropriate access, but on preparing participants for sustained success on these medications, protecting both outcomes and employer investment
Composition: 30 mg Tirzepatide (lyophilized peptide powder) Molecular class: Dual GIP/GLP-1 incretin agonist Form: Sterile freeze-dried powder in a sealed vial Administration: Subcutaneous research application (requires reconstitution) Purity: 98% (HPLC-verified) What Is Tirzepatide
Fatigue is more likely, affecting approximately 5% of users formally, though many more experience mild tiredness
Below are four targeted protocols that cover the most common scenarios for GLP-1 users
The result: federated models matched the performance of pooling all data centrally